07.02.2024 GREAT NEWS ARTICLE

  ·  

07.02.2024 THE ERA OF GENERATIVE AI STARTUPS

  ·  

20.03.2024 LOREM IPSUM

  ·  

07.02.2024 GREAT NEWS ARTICLE

  ·  

07.02.2024 THE ERA OF GENERATIVE AI STARTUPS

  ·  

20.03.2024 LOREM IPSUM

  ·  

07.02.2024 GREAT NEWS ARTICLE

  ·  

07.02.2024 THE ERA OF GENERATIVE AI STARTUPS

  ·  

20.03.2024 LOREM IPSUM

  ·  

07.02.2024 GREAT NEWS ARTICLE

  ·  

07.02.2024 THE ERA OF GENERATIVE AI STARTUPS

  ·  

20.03.2024 LOREM IPSUM

  ·  

07.02.2024 GREAT NEWS ARTICLE

  ·  

07.02.2024 THE ERA OF GENERATIVE AI STARTUPS

  ·  

20.03.2024 LOREM IPSUM

  ·  

07.02.2024 GREAT NEWS ARTICLE

  ·  

07.02.2024 THE ERA OF GENERATIVE AI STARTUPS

  ·  

20.03.2024 LOREM IPSUM

  ·  

07.02.2024 GREAT NEWS ARTICLE

  ·  

07.02.2024 THE ERA OF GENERATIVE AI STARTUPS

  ·  

20.03.2024 LOREM IPSUM

  ·  

07.02.2024 GREAT NEWS ARTICLE

  ·  

07.02.2024 THE ERA OF GENERATIVE AI STARTUPS

  ·  

20.03.2024 LOREM IPSUM

  ·  

07.02.2024 GREAT NEWS ARTICLE

  ·  

07.02.2024 THE ERA OF GENERATIVE AI STARTUPS

  ·  

20.03.2024 LOREM IPSUM

  ·  

07.02.2024 GREAT NEWS ARTICLE

  ·  

07.02.2024 THE ERA OF GENERATIVE AI STARTUPS

  ·  

20.03.2024 LOREM IPSUM

  ·  
MAKING HEALTH INNOVATION INVESTABLE
Logo

ARETI Europe is the corporate venture capital arm of Evnia Group. It is a €100M pan-European pre-seed to Series A+ HealthTech and BioTech venture capital fund, designed to back liquidity and human capital by transforming regulatory and clinical complexity into investable, deployable, and acquirable assets.

100+

Startups

50+

Operators

4

Countries
Our holistic approach and perceptional setup
is our biggest asset and your greatest strength

Venture Capital

Sourcing, backing, and accelerating existing HealthTech ventures toward acquisition-ready outcomes.

Venture Studio

Co-building new HealthTech ventures from scratch; all it takes is a novel idea, a “learner” founder persona, and a structured assessment. Leave the rest to us.

Evnia Health Hub

The operational backbone that helps us deliver our regulatory, clinical, and commercial execution promises.

Portfolio Companies
A REMEDY FOR SUCCESS
THROUGH EXEMPLARY PARADIGMS
A REMEDY FOR SUCCESS
THROUGH EXEMPLARY PARADIGMS